FDA
The U.S. Food and Drug Administration regulates drugs, biologics, medical devices, diagnostics, and certain software products.
Reference
Glossary
A working glossary for healthcare-system, regulatory, payment, and market-access terms used throughout the site.
NMPA
The National Medical Products Administration is China’s primary regulator for drugs and medical devices.
NHSA
The National Healthcare Security Administration is central to China’s insurance, pricing, reimbursement, and procurement reforms.
NHC
The National Health Commission oversees major health policy, public health, hospitals, and system administration.
Coverage
Coverage refers to whether a payer will pay for a service or product under defined circumstances.
Reimbursement
Reimbursement refers to payment for a covered service or product, including amount, billing pathway, and payer rules.
Volume-Based Procurement
A Chinese centralized purchasing policy that uses purchase volume commitments to reduce prices for selected drugs or devices.
Internet Hospital
A regulated Chinese model for online healthcare services connected to licensed medical institutions.
China system terms
China system terms
Basic Medical Insurance
The broad public insurance structure that finances much of covered medical care in China, with local benefit variation.
County Hospital
A county-level hospital that anchors local access and connects rural patients to higher-level referral systems.
Medical Alliance
An organizational linkage among hospitals and lower-level providers intended to improve coordination and tiered care.
Family Doctor Program
A contracted primary-care model intended to improve continuity, prevention, and chronic disease management.
Health Informatization
The development of digital systems for hospitals, public health, insurance, administration, and regional platforms.
Out-of-Pocket Spending
The portion of healthcare cost paid directly by households rather than by insurance or government funding.
Hospital terms
Chinese hospital system terms
Tier 3 Hospital
A high-level hospital category associated with advanced care, referral capacity, specialists, and institutional prestige.
Tertiary Grade A Hospital
A top-grade hospital classification often used as shorthand for elite hospital status, though specialty strength still varies.
Hospital Accreditation
A formal evaluation process tied to hospital capability, quality systems, management, and classification.
Medical Alliance
A network arrangement linking higher-level hospitals with lower-level facilities to support referral and capacity building.
Public Hospital Governance
The administrative, financial, clinical, and policy structure that shapes public hospital behavior.
Hospital profile terms
Major hospital profile terms
Academic Medical Center
A hospital with major teaching, research, and advanced-care functions, often linked to a university or medical college.
Referral Hospital
A hospital that receives patients from lower-level facilities or broader regions for more complex care.
Specialty Hospital
A hospital organized around a disease area, patient population, medical discipline, or clinical service line.
Hospital Profile
A structural page explaining an institution’s role rather than a current rating or quality endorsement.
Clinical Credibility
The trust a product, service, or care model gains from use or support by respected clinical institutions or experts.
Regional healthcare terms
City and regional profile terms
City Healthcare Geography
A profile format that explains how a city functions as a healthcare node, including hospitals, referral patterns, and regional role.
Regional Referral Center
A hospital or city that receives patients from a broader region for more complex care.
Municipal Healthcare System
The healthcare delivery, public-health, provider, and administrative environment within a municipality or city.
Academic Hospital Network
A group of hospitals connected to a university or medical school that may influence teaching, research, and clinical practice.
Regional Market Access
The process of assessing whether a product or service can gain adoption within a city, province, or regional healthcare market.
Regional healthcare terms
Province and regional profile terms
Province Healthcare Profile
A page that explains a province as a healthcare geography, including anchor cities, hospitals, access constraints, and policy implementation.
Macro-Region Healthcare Profile
A page that explains a multi-province area such as western China, the Greater Bay Area, or the Yangtze River Delta.
Anchor City
A city that organizes regional healthcare capacity through major hospitals, universities, referral flows, and administrative influence.
Regional Health Inequality
Variation in access, capacity, affordability, or outcomes across provinces, cities, rural areas, and remote regions.
Cross-Border Health Corridor
A region where healthcare activity is shaped by adjacent jurisdictions, travel, policy coordination, or institutional exchange.
Insurance terms
Chinese insurance and reimbursement terms
Basic Medical Insurance
The broad public medical insurance system that finances much of covered care in China, with local variation in benefits and reimbursement.
UEBMI
Urban Employee Basic Medical Insurance, an employment-linked basic medical insurance arrangement.
URBMI
Urban Resident Basic Medical Insurance, a legacy resident coverage category important to reform history.
NRCMS
New Rural Cooperative Medical Scheme, a legacy rural coverage program central to rural insurance expansion.
NRDL
National Reimbursement Drug List, the key reimbursement list for medicines under basic medical insurance.
NHSA
National Healthcare Security Administration, the agency central to insurance, payment, pricing, and procurement reform.
City Supplemental Insurance
Locally sponsored or city-linked supplemental insurance designed to fill selected gaps in basic coverage.
Payment terms
Chinese payment and procurement terms
Volume-Based Procurement
A purchasing mechanism that links committed volume to lower prices for selected drugs, devices, or consumables.
DRG Payment
A payment method that groups cases by diagnosis-related categories to constrain open-ended fee-for-service incentives.
DIP Payment
A Chinese payment reform using data-driven diagnosis-intervention packets and point-based local fund management.
Two-Invoice System
A distribution reform intended to reduce intermediary layers and markups in pharmaceutical distribution.
High-Value Medical Consumables
Device and consumable categories, such as implants or procedure-linked products, that can be subject to procurement pressure.
Zero Markup Drug Policy
A reform that removed hospital drug markups and forced compensation and service-pricing changes.
Medicine and history terms
Chinese medical history and TCM terms
Barefoot Doctors
Community-based rural health workers associated with Mao-era cooperative medicine and basic rural care.
Patriotic Health Campaigns
Mass public-health mobilization campaigns focused on sanitation, prevention, vector control, and local participation.
Traditional Chinese Medicine
A formalized field of practice, education, hospitals, products, regulation, and cultural identity in China.
TCM Hospital
A state-recognized medical institution organized around Traditional Chinese Medicine services, often within modern hospital infrastructure.
Chinese Herbal Medicine
A TCM practice and product category involving formulas, prepared products, raw materials, quality control, and regulation.
Acupuncture
A TCM-associated practice used in China and internationally, with evidence and policy debates varying by condition and setting.
Population health terms
Disease burden and public-health terms
Chronic Disease
A long-duration condition requiring prevention, monitoring, medication management, follow-up, and often coordination between primary and specialty care.
Disease Burden
The population-level impact of illness, disability, death, and care needs, often used to connect epidemiology with health-system priorities.
Maternal Mortality
Deaths related to pregnancy or childbirth, used as an indicator of maternal health and system capacity.
Infant Mortality
Deaths among infants, used as an indicator of child health, neonatal care, public health, and social conditions.
Cardiovascular Disease
Heart and vascular disease, including conditions that require prevention, acute care, procedures, rehabilitation, and long-term management.
Public Health Surveillance
The systematic collection and use of health data for disease control, outbreak response, and population-health management.
Aging and access terms
Aging, migration, and social-protection terms
Long-Term Care
Functional, social, and medical support for people with sustained care needs due to aging, disability, illness, or frailty.
Hukou
China’s household registration system, which can affect access to public services, insurance administration, and local benefits.
Medical Poverty
Financial hardship or impoverishment caused by illness costs despite insurance or assistance.
Catastrophic Illness
Severe or high-cost illness that can expose the limits of insurance coverage and household financial resilience.
Left-Behind Children
Children remaining in their home communities while one or both parents migrate for work.
Orphan Drug
A medicine intended for a rare disease, requiring separate analysis of approval, pricing, reimbursement, and access.
U.S. healthcare terms
U.S. payer, provider, and reimbursement terms
Medicare
A federal U.S. health insurance program primarily serving older adults and selected disabled populations.
Medicaid
A joint state-federal U.S. program covering low-income and medically vulnerable populations, with substantial state variation.
Employer-Sponsored Insurance
Health insurance offered through employment and a central coverage source for working-age Americans.
Medicare Advantage
Private-plan Medicare coverage administered by contracted plans using managed-care tools.
Pharmacy Benefit Manager
An intermediary that administers prescription drug benefits, formulary design, pharmacy networks, and rebate arrangements.
Prior Authorization
A utilization management process requiring payer approval before selected services, drugs, devices, or procedures are covered.
Comparison terms
U.S.-China comparative analysis terms
Comparative Health System Analysis
A method that compares institutions, incentives, financing, regulation, and patient pathways rather than country labels alone.
Fragmented Pluralism
A useful shorthand for U.S. healthcare’s multiple payer, provider, regulatory, and contractual structures.
State-Steered Local Implementation
A useful shorthand for Chinese healthcare policy, where central direction is translated through provincial, municipal, and hospital-level implementation.
Commercial Pathway
The chain from regulatory permission to payment, procurement, adoption, and patient access.
Data Localization
A requirement or policy pressure that keeps certain data processing, storage, transfer, or governance within a jurisdiction.
Healthcare AI Governance
The rules and institutions governing clinical AI safety, data use, validation, deployment, monitoring, and accountability.
Regulatory terms
Regulatory approval and lifecycle-governance terms
FDA
The U.S. Food and Drug Administration, the federal agency regulating drugs, biologics, medical devices, diagnostics, and certain software-based medical products.
NMPA
China’s National Medical Products Administration, the agency responsible for regulating drugs, medical devices, cosmetics, and related product registration.
Software as a Medical Device
Software intended for one or more medical purposes that performs those purposes without being part of a hardware medical device.
Real-World Evidence
Clinical evidence about product use and outcomes derived from analysis of real-world data, subject to fit-for-purpose quality tests.
Pharmacovigilance
The system for detecting, assessing, understanding, and preventing adverse drug reactions and related drug safety risks.
Postmarket Surveillance
Lifecycle monitoring after approval or registration, including adverse event reporting, signal detection, field action, and benefit-risk management.
Regulatory Localization
The adaptation of a global regulatory dossier, claim, evidence plan, labeling, data strategy, and postmarket system to local regulatory requirements.
Biopharma terms
Biopharma strategy, supply-chain, and commercialization terms
Active Pharmaceutical Ingredient
The pharmacologically active component of a medicine, distinct from excipients, packaging, and finished-dose formulation.
CDMO
A contract development and manufacturing organization that provides development, manufacturing, analytical, or supply services for life-sciences companies.
CRO
A contract research organization that supports clinical trials, regulatory submissions, data management, monitoring, and development operations.
Biosimilar
A biological product that is highly similar to an approved reference biologic, requiring comparability evidence rather than ordinary generic-drug logic.
NRDL Strategy
A drug market-access strategy built around China’s National Reimbursement Drug List, price negotiation, patient affordability, and hospital access.
Technology Transfer
The controlled movement of process know-how, data, methods, biological materials, software, or manufacturing capability between organizations.
Medtech terms
Medical device, diagnostics, laboratory, and procurement terms
High-Value Medical Consumables
Costly, procedure-linked medical devices or materials, such as implants or specialist-use products, that are often exposed to procurement reform.
In Vitro Diagnostic
A diagnostic test performed on specimens taken from the human body, such as blood, tissue, or other samples.
Point-of-Care Testing
Diagnostic testing performed near the patient or clinical decision point rather than in a central laboratory.
Digital Pathology
The use of scanned pathology slides, image-management systems, and related software for pathology review, consultation, or analysis.
Reference Laboratory
A laboratory that receives specimens from other providers for specialized or centralized testing.
Device Distributor
A channel partner that supports hospital access, logistics, tendering, service coordination, or sales for medical devices.
Digital health terms
Digital health, AI, interoperability, and data terms
Internet Hospital
A regulated China-specific online medical institution model, often linked to physical hospitals or platform-based healthcare services.
Digital Therapeutic
A software-based intervention intended to treat or manage a disease or condition, requiring clinical evidence and a payment pathway.
Remote Patient Monitoring
The collection and review of patient health data outside traditional care settings, usually requiring a care-management workflow.
Information Blocking
A U.S. policy concept involving practices that interfere with access, exchange, or use of electronic health information except as permitted by law or regulation.
Healthcare Interoperability
The ability of health data systems to exchange and use information meaningfully across organizations, platforms, and care settings.
Cross-Border Health Data
Health-related data that move or are accessed across jurisdictions, creating privacy, security, localization, consent, and governance risks.
Market-entry terms
China healthcare market-entry and commercialization terms
Market Access
The pathway by which a product moves from approval or availability to practical use through payment, procurement, hospital access, and adoption.
Tendering
A procurement process in which qualified suppliers compete under specified purchasing, price, quality, or volume rules.
KOL Strategy
A structured approach to legitimate engagement with scientific, clinical, or institutional experts who influence evidence, training, and adoption.
Localization Strategy
The adaptation of product claims, evidence, service, data architecture, manufacturing, price, and commercial model to local market conditions.
Commercial Due Diligence
A structured assessment of market attractiveness, adoption barriers, competitive position, payment route, channel feasibility, and execution risk.
Regulatory Sequencing
The ordering of classification, evidence, submission, partner, data, reimbursement, and channel decisions to avoid rework and weak approvals.
U.S. entry terms
U.S. reimbursement, FDA, coding, and commercialization terms
FDA Readiness
The degree to which a product claim, evidence package, quality system, documentation, labeling, and postmarket plan are prepared for FDA interaction.
CPT Code
A code set used to identify medical services and procedures, especially physician and other professional services.
HCPCS
A coding system used by Medicare and other payers that includes CPT codes and additional codes for products, supplies, and services.
Coverage Strategy
The plan for obtaining payer recognition that a product or service is medically necessary and payable for specified patients or indications.
Hospital Value Analysis Committee
A hospital committee or process that evaluates new products for clinical, operational, safety, supply-chain, and economic value.
Postmarket Support
The service, complaint handling, training, quality, reporting, repair, and customer-success infrastructure after product launch.
Governance terms
Chinese healthcare agency, law, and stakeholder terms
National Health Commission
China’s central health administration body with major roles in health planning, delivery-system policy, public health, and medical service administration.
National Medical Products Administration
China’s regulator for drugs, medical devices, diagnostics, cosmetics, and related product registration and postmarket regulation.
China CDC
China’s public-health institution for disease prevention, surveillance, technical guidance, public-health research, and outbreak-related functions.
Healthy China 2030
A broad national health strategy framing long-term prevention, health promotion, public health, delivery reform, and population-health priorities.
PIPL
China’s Personal Information Protection Law, a major personal-information governance law with important implications for health data.
Health Technology Assessment
An evidence process that evaluates clinical, economic, budget, and implementation value to inform reimbursement, pricing, procurement, or policy decisions.
Provider-market terms
China provider market, private care, and service-line terms
Public Hospital Reform
Policy efforts to change public hospital incentives through pricing, payment, procurement, compensation, governance, and quality reforms.
Premium Private Healthcare
Private care targeted to affluent, expatriate, employer-covered, or internationally insured patients seeking convenience, service quality, or specialist access.
International Hospital
A private or premium hospital segment oriented toward foreign-facing, multilingual, internationally insured, or high-service-standard care.
Health Checkup Center
A preventive screening and health-assessment business model often tied to employer benefits, private pay, and diagnostic packages.
Service-Line Strategy
A planning framework for developing a specialty area such as oncology, cardiology, diabetes, rehabilitation, ophthalmology, or dental care.
Commercial Payer Strategy
A strategy for working with commercial insurers or supplemental payers rather than relying only on basic medical insurance.
中文术语桥
美国医疗体系常用术语中文解释
Coverage
支付方是否愿意在特定条件下支付某项医疗服务、产品或药品。
Reimbursement
实际支付路径和支付金额，包括谁收款、收多少、在哪种服务场景下收。
CPT
美国医疗服务和程序编码体系中的核心代码体系之一，常用于描述专业服务和程序。
HCPCS
美国医疗编码体系之一，常用于 Medicare 和其他支付流程中的产品、供应品和服务识别。
Prior Authorization
支付方要求某些服务、药品、检查或器械在支付前先获批准的使用管理机制。
Value Analysis Committee
美国医院评估新产品临床、运营、供应链和经济价值的采购相关机制。
中文深化术语
美国医疗编码、支付、监管和医院采购术语
ICD-10-CM
美国诊断编码语境中常用的 ICD-10 临床修订版本，用于描述诊断和医学必要性背景。
DRG
诊断相关组，用于住院病例分组和支付或管理分析。
PBM
Pharmacy Benefit Manager，管理处方药福利、formulary、返点、药房网络和使用管理的中介机构。
CPT Category III
面向新兴技术、服务和程序的临时代码，不自动代表成熟支付。
Medicare Coverage
Medicare 是否在特定条件下覆盖服务或产品，可能涉及 NCD、LCD 和合理必要性标准。
Value Analysis
医院对新产品的临床、经济、运营、供应链和风险价值进行评估的流程。
Methods and evidence
Sources, evidence standards, and data guides
These pages explain how the site evaluates sources, weighs evidence, uses official data, maintains terminology, supports Chinese-language readers, and preserves historical material.
Sourcessource families and evidence context
Evidence Gradingevidence grades used across pages
Update Policy
Data Sources for China Healthcareannotated guide to Chinese health data sources
Data Sources for U.S. Healthcareannotated guide to U.S. health data sources
Annotated Bibliography for Healthcare in Chinacore source set for China system pages
Annotated Bibliography for Chinese Healthcare Reformsource set for reform pages
Annotated Bibliography for Traditional Chinese Medicinesource set for TCM pages
Annotated Bibliography for U.S.-China Healthcaresource set for comparison and cross-border pages
All Pages Directoryfull human-readable directory
Citation Stylesource-note format for static pages
Chinese Translation Style Guideterminology and selective translation
Chinese Access Layer Policywhy Chinese pages are selective
Archive Preservation Policyold conference pages and historical content
Editorial terms
Source, evidence, and reference terms
Source family
A category of evidence source, such as official agency material, administrative data, peer-reviewed literature, field evidence, or strategic inference.
Evidence grade
A practical confidence label based on the type of source supporting a claim and the decision it is meant to inform.
Archive preservation
A policy of retaining historical pages while keeping them separate from current guidance.
Chinese access layer
A selective simplified Chinese explanation layer for high-value cross-border topics rather than a full mirror of the English site.
Reference guides
Indices, FAQs, agency glossary, and timelines
These pages provide concise entry points into system, hospital, province, insurance, reform, TCM, population health, medtech, biopharma, digital health, market entry, regulatory, Chinese reader, FAQ, agency, and timeline topics.
Health Systems Indexsystem-level pages across U.S., China, and comparisons
China Hospitals Directoryhospital architecture and hospital-related pages
China Provinces Healthcare Indexprovince and region healthcare profiles
China Health Insurance DirectoryChina insurance, financing, reimbursement, and payment pages
China Healthcare Reform Directoryreform briefs and policy instruments
Traditional Chinese Medicine DirectoryTCM history, regulation, institutions, and debate
Population Health in China Indexhealth indicators and disease-burden pages
Medtech Indexdevice, diagnostic, procurement, and channel pages
Biopharma Indexdrug, trial, supply chain, and licensing pages
Digital Health and AI Indexdigital health, AI, data, and cybersecurity pages
Market Entry IndexU.S.-to-China and China-to-U.S. strategy pages
Regulatory Pathways IndexFDA, NMPA, trial, device, drug, and diagnostic pathway pages
U.S. Healthcare for Chinese Readers IndexChinese-language and U.S. system pages for Chinese readers
U.S.-China Healthcare FAQtop-level comparison questions
China Healthcare FAQChinese healthcare system questions
U.S. Market Entry FAQ for Chinese Healthcare CompaniesChina-to-U.S. commercialization
Common Mistakes in U.S.-China Healthcare Comparisonsfalse equivalences and generic comparison mistakes
Glossary of Chinese Healthcare Agenciesagency-specific glossary and index
Timeline of Chinese Healthcare Reformchronological reform spine linking reform pages
Timeline of U.S.-China Healthcare Relationshistorical relationship without daily-news framing
Navigation terms
Index, FAQ, and timeline terms
Topical index
A navigation page that groups related pages by decision problem rather than by alphabetical order.
Health systems index
A site index that groups system-level U.S., China, and comparative healthcare pages.
Market entry index
A site index for cross-border commercialization, reimbursement, procurement, partner, and readiness pages.
Regulatory pathways index
A site index for FDA, NMPA, clinical trial, drug, device, diagnostic, postmarket, and evidence pathway pages.
Myth-versus-fact page
A page structure used to correct false equivalences and common interpretation errors.
Timeline page
A chronological orientation page that links historical developments to current analytical clusters.